​

Phio Pharmaceuticals Ownership | Who Owns Phio Pharmaceuticals?

OverviewFinancialsChart

Phio Pharmaceuticals Ownership Summary

Phio Pharmaceuticals is owned by 5.75% institutional investors, 6.00% insiders, and 88.25% retail investors. Macquarie Healthcare I is the top mutual fund, with 0.87% of its assets in Phio Pharmaceuticals shares.

PHIO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockPhio Pharmaceuticals5.75%6.00%88.25%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202624-668,490-5-24---
Jun 30, 202511-164,722-3-11---
Dec 31, 202211-15.38%575,219-20.85%414.91%3-57.14%775.00%
Sep 30, 20221330.00%726,716-6.72%516.35%7133.33%4-33.33%
Jun 30, 202210-23.08%779,03610.17%520.98%3-57.14%620.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Macquarie Healthcare I50.00K0.87%-
Fidelity Extended Market Index94.61K0.81%36.51K
Vanguard Institutional Extnd Mkt Idx Tr94.26K0.81%14.41K
Nomura Healthcare Fund Class I50.00K0.43%-
Bridgeway Ultra-Small Company23.49K0.30%-
Spartan Extended Market Index Pool E7.45K0.18%7.41K
Spartan Extended Market Index Pool F17.13K0.15%8.59K
NT Ext Equity Mkt Idx Fd - L15.35K0.13%-
Northern Trust Extended Eq Market Idx15.35K0.13%15.30K
NT Ext Equity Mkt Index Fund - Lending15.35K0.13%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 31, 2025Bitterman Robert J Chairman, Pres. & CEOBuy$5.15K
Dec 23, 2025Bitterman Robert J Chairman, Pres. & CEOBuy$5.10K
Nov 21, 2025Bitterman Robert J Chairman, Pres. & CEOBuy$5.70K
Nov 18, 2025Bitterman Robert J Chairman, Pres. & CEOBuy$6.35K
Jun 10, 2025Bitterman Robert J Chairman, Pres & CEOBuy$4.84K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q44-
2025 Q3--
2025 Q26-
2025 Q1--

PHIO Ownership FAQ

Who Owns Phio Pharmaceuticals?

Phio Pharmaceuticals shareholders are primarily institutional investors at 5.75%, followed by 6.00% insiders and 88.25% retail investors. The average institutional ownership in Phio Pharmaceuticals's industry, Biotech Stocks , is 35.75%, which Phio Pharmaceuticals falls below.

Does Blackrock own Phio Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Phio Pharmaceuticals.

Who is the top mutual fund holder of Phio Pharmaceuticals shares?

Macquarie Healthcare I is the top mutual fund holder of Phio Pharmaceuticals shares, with 0.87% of its total shares outstanding invested in 50K Phio Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools